These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 37500754)

  • 1. Nonclassical mechanisms to irreversibly suppress β-hematin crystal growth.
    Ma W; Balta VA; Pan W; Rimer JD; Sullivan DJ; Vekilov PG
    Commun Biol; 2023 Jul; 6(1):783. PubMed ID: 37500754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of hematin crystallization and inhibition by the antimalarial drug chloroquine.
    Olafson KN; Ketchum MA; Rimer JD; Vekilov PG
    Proc Natl Acad Sci U S A; 2015 Apr; 112(16):4946-51. PubMed ID: 25831526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A second mechanism employed by artemisinins to suppress Plasmodium falciparum hinges on inhibition of hematin crystallization.
    Ma W; Balta VA; West R; Newlin KN; Miljanić OŠ; Sullivan DJ; Vekilov PG; Rimer JD
    J Biol Chem; 2021; 296():100123. PubMed ID: 33239360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimalarials inhibit hematin crystallization by unique drug-surface site interactions.
    Olafson KN; Nguyen TQ; Rimer JD; Vekilov PG
    Proc Natl Acad Sci U S A; 2017 Jul; 114(29):7531-7536. PubMed ID: 28559329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Considerations on the mechanism of action of artemisinin antimalarials: part 1--the 'carbon radical' and 'heme' hypotheses.
    Haynes RK; Cheu KW; N'Da D; Coghi P; Monti D
    Infect Disord Drug Targets; 2013 Aug; 13(4):217-77. PubMed ID: 24304352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heme Detoxification in the Malaria Parasite: A Target for Antimalarial Drug Development.
    de Villiers KA; Egan TJ
    Acc Chem Res; 2021 Jun; 54(11):2649-2659. PubMed ID: 33982570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deconstructing Quinoline-Class Antimalarials to Identify Fundamental Physicochemical Properties of Beta-Hematin Crystal Growth Inhibitors.
    Olafson KN; Nguyen TQ; Vekilov PG; Rimer JD
    Chemistry; 2017 Oct; 23(55):13638-13647. PubMed ID: 28833627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro beta-hematin formation assays with plasma of mice infected with Plasmodium yoelii and other parasite preparations: comparative inhibition with quinoline and endoperoxide antimalarials.
    Tripathi AK; Gupta A; Garg SK; Tekwani BL
    Life Sci; 2001 Oct; 69(23):2725-33. PubMed ID: 11720077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crystal nucleation, growth, and morphology of the synthetic malaria pigment beta-hematin and the effect thereon by quinoline additives: the malaria pigment as a target of various antimalarial drugs.
    Solomonov I; Osipova M; Feldman Y; Baehtz C; Kjaer K; Robinson IK; Webster GT; McNaughton D; Wood BR; Weissbuch I; Leiserowitz L
    J Am Chem Soc; 2007 Mar; 129(9):2615-27. PubMed ID: 17290993
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Singh R; Singh R; Srihari V; Makde RD
    ACS Infect Dis; 2023 Aug; 9(8):1647-1657. PubMed ID: 37471056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimalarial Quinoline Drugs Inhibit β-Hematin and Increase Free Hemin Catalyzing Peroxidative Reactions and Inhibition of Cysteine Proteases.
    Herraiz T; Guillén H; González-Peña D; Arán VJ
    Sci Rep; 2019 Oct; 9(1):15398. PubMed ID: 31659177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth of Large Hematin Crystals in Biomimetic Solutions.
    Olafson KN; Rimer JD; Vekilov PG
    Cryst Growth Des; 2014 May; 14(5):2123-2127. PubMed ID: 24839403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparative observation on inhibition of hemozoin formation and their in vitro and in vivo anti-schistosome activity displayed by 7 antimalarial drugs].
    Xue J; Jiang B; Liu CS; Sun J; Xiao SH
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2013 Jun; 31(3):161-9. PubMed ID: 24812850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Definition of an electronic profile of compounds with inhibitory activity against hematin aggregation in malaria parasite.
    Portela C; Afonso CM; Pinto MM; Ramos MJ
    Bioorg Med Chem; 2004 Jun; 12(12):3313-21. PubMed ID: 15158799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quinoline antimalarials decrease the rate of beta-hematin formation.
    Egan TJ; Ncokazi KK
    J Inorg Biochem; 2005 Jul; 99(7):1532-9. PubMed ID: 15927260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interactions of quinoline antimalarials with hematin in solution.
    Egan TJ
    J Inorg Biochem; 2006 May; 100(5-6):916-26. PubMed ID: 16384600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting the hemozoin synthesis pathway for new antimalarial drug discovery: technologies for in vitro beta-hematin formation assay.
    Tekwani BL; Walker LA
    Comb Chem High Throughput Screen; 2005 Feb; 8(1):63-79. PubMed ID: 15720198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Solvent Structure and Dynamics near the Surfaces of β-Hematin Crystals.
    Verma L; Vekilov PG; Palmer JC
    J Phys Chem B; 2021 Oct; 125(40):11264-11274. PubMed ID: 34609878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting of hematin by the antimalarial pyronaridine.
    Auparakkitanon S; Chapoomram S; Kuaha K; Chirachariyavej T; Wilairat P
    Antimicrob Agents Chemother; 2006 Jun; 50(6):2197-200. PubMed ID: 16723583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.